Next |
home / stock / edsa / edsa message board
Subject | By | Source | When |
---|---|---|---|
$EDSA: Hey, big THANKS to ya, Capt. S-L!!! | Invest-in-America | investorshub | 01/06/2023 1:51:37 AM |
Hey my brother I feel great that you | subslover | investorshub | 01/06/2023 1:04:59 AM |
$EDSA: Hey, & YOU'RE stock picks, Sir, have | Invest-in-America | investorshub | 01/04/2023 9:10:23 PM |
$2,26 close so that dip last week was | subslover | investorshub | 01/04/2023 9:02:12 PM |
Once the volume picks up, we will have | subslover | investorshub | 01/04/2023 6:57:00 PM |
$EDSA: And THAT one, too!!! GO-GO-GO!!! | Invest-in-America | investorshub | 01/04/2023 6:53:45 PM |
$2.25 and looiking up! LOL | subslover | investorshub | 01/04/2023 6:47:07 PM |
POP @ $2.14 up 23% LMAO. :) | subslover | investorshub | 12/31/2022 1:41:18 AM |
znewcar1: $EDSA 24% v636K c2.16 f19,353M H2.20 ML.84 YL1.51 off 10dma | znewcar1 | investorshangout | 12/30/2022 9:55:13 PM |
Dip then rip! | subslover | investorshub | 12/29/2022 8:25:34 PM |
lol | gail | investorshub | 12/28/2022 8:46:49 PM |
$EDSA; YEP!!! That's how the SMART players do | Invest-in-America | investorshub | 12/28/2022 8:45:02 PM |
watching for poss re entry here. | gail | investorshub | 12/28/2022 8:34:26 PM |
$EDSA: Hey, I hear-ya on THAT note, 'S-S' | Invest-in-America | investorshub | 12/28/2022 2:08:02 PM |
Geeze dude, I hope that got prepared you | subslover | investorshub | 12/28/2022 3:58:47 AM |
$EDSA: Yep!! it sure is, Dude!!! (Sorry for | Invest-in-America | investorshub | 12/27/2022 9:37:10 PM |
Is this a beautiful stock or what! 2023 | subslover | investorshub | 12/27/2022 6:11:24 PM |
$EDSA: Get ready, Girl!!! X-Mass ain't over quite yet!!! | Invest-in-America | investorshub | 12/27/2022 3:12:41 PM |
its trying, but manipulation is king for now. | gail | investorshub | 12/27/2022 2:35:52 PM |
$EDSA: COFFEE!!! It perks-you-UP!!! I calms-you-DOWN!!! (Let's go, EDS | Invest-in-America | investorshub | 12/27/2022 2:19:50 PM |
News, Short Squeeze, Breakout and More Instantly...
This Phase 2 clinical study will evaluate paridiprubart (EB05) in hospitalized patients with acute respiratory distress syndrome (ARDS) due to a variety of causes. This BARDA-funded project is expected to complement Edesa's ongoing drug development activities in COVID-19 ARDS. Paridipru...
TORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provid...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...